{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:19:02Z","timestamp":1775841542470,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T00:00:00Z","timestamp":1727568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T00:00:00Z","timestamp":1727568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-024-04790-y","type":"journal-article","created":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T00:02:15Z","timestamp":1727568135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Asymptomatic thrombocytopenia after nintedanib initiation in a patient with progressive pulmonary fibrosis: a case report and review of literature"],"prefix":"10.1186","volume":"18","author":[{"given":"Xinxin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nannan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiemei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,29]]},"reference":[{"issue":"12","key":"4790_CR1","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJMoa1103690","volume":"365","author":"L Richeldi","year":"2011","unstructured":"Richeldi L, Costabel U, Selman M, Kim DS, Hansell DM, Nicholson AG, Brown KK, Flaherty KR, Noble PW, Raghu G, et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med. 2011;365(12):1079\u201387.","journal-title":"N Engl J Med"},{"issue":"1","key":"4790_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/ijms22010282","volume":"22","author":"G Grzesk","year":"2020","unstructured":"Grzesk G, Wozniak-Wisniewska A, Blazejewski J, Gorny B, Wolowiec L, Rogowicz D, Nowaczyk A. The interactions of nintedanib and oral anticoagulants-molecular mechanisms and clinical implications. Int J Mol Sci. 2020;22(1):282.","journal-title":"Int J Mol Sci"},{"issue":"18","key":"4790_CR3","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, et al. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med. 2019;381(18):1718\u201327.","journal-title":"N Engl J Med"},{"issue":"5","key":"4790_CR4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/medicina59050999","volume":"59","author":"I Dumic","year":"2023","unstructured":"Dumic I, Charokopos A, Parmar A, Grant CR, Cosiquien RJS, Dagnon da Silva M, Petcu E. Drug-induced thrombocytopenia due to nintedanib during treatment of idiopathic pulmonary fibrosis. Medicina. 2023;59(5):999.","journal-title":"Medicina"},{"issue":"7","key":"4790_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.628","volume":"8","author":"Y Ochi","year":"2020","unstructured":"Ochi Y, Kato M, Fujioka M, Hayashi M, Takagi H, Takahashi K. Thrombocytopaenia during nintedanib treatment in a patient with idiopathic pulmonary fibrosis. Respirol Case Rep. 2020;8(7): e00628.","journal-title":"Respirol Case Rep"},{"issue":"6","key":"4790_CR6","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3324\/haematol.2021.279484","volume":"107","author":"I Marini","year":"2022","unstructured":"Marini I, Uzun G, Jamal K, Bakchoul T. Treatment of drug-induced immune thrombocytopenias. Haematologica. 2022;107(6):1264\u201377.","journal-title":"Haematologica"},{"issue":"12","key":"4790_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.21037\/atm.2019.05.33","volume":"7","author":"M Nakamura","year":"2019","unstructured":"Nakamura M, Okamoto M, Fujimoto K, Ebata T, Tominaga M, Nouno T, Zaizen Y, Kaieda S, Tsuda T, Kawayama T, et al. A retrospective study of the tolerability of nintedanib for severe idiopathic pulmonary fibrosis in the real world. Ann Transl Med. 2019;7(12):262.","journal-title":"Ann Transl Med"},{"issue":"11","key":"4790_CR8","doi-asserted-by":"publisher","first-page":"e48898","DOI":"10.7759\/cureus.48898","volume":"15","author":"ZA Qureshi","year":"2023","unstructured":"Qureshi ZA, Altaf F, Khanzada M, Thet A, Espinosa L. Ceftriaxone-induced thrombotic thrombocytopenic purpura treated successfully with plasmapheresis and eculizumab: a rare case report. Cureus. 2023;15(11):e48898. https:\/\/doi.org\/10.7759\/cureus.48898.","journal-title":"Cureus."},{"issue":"1","key":"4790_CR9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1186\/s12879-022-07925-y","volume":"22","author":"R Mistry","year":"2022","unstructured":"Mistry R, Rawson TM, Troise O, Mughal N, Moore LSP, Hughes S. Haematological and hepatic adverse effects of ceftriaxone in ambulatory care: a dual-centre retrospective observational analysis of standard vs high dose. Abstract BMC Infect Dis. 2022;22(1):959. https:\/\/doi.org\/10.1186\/s12879-022-07925-y.","journal-title":"Abstract BMC Infect Dis."},{"issue":"5","key":"4790_CR10","first-page":"891","volume":"38","author":"M Giannini","year":"2020","unstructured":"Giannini M, Grignaschi S, Fornaro M, Caporali R, Locatelli F, Zanframundo G, Meyer A, Montecucco C, Iannone F, Paolino S, et al. Thrombocytopenia in idiopathic inflammatory myopathies: a case series analysis. Clin Exp Rheumatol. 2020;38(5):891\u20135.","journal-title":"Clin Exp Rheumatol"},{"issue":"13","key":"4790_CR11","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1182\/bloodadvances.2020001640","volume":"4","author":"AJG Jansen","year":"2020","unstructured":"Jansen AJG, Spaan T, Low HZ, Di Iorio D, van den Brand J, Tieke M, Barendrecht A, Rohn K, van Amerongen G, Stittelaar K, et al. Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity. Blood Adv. 2020;4(13):2967\u201378.","journal-title":"Blood Adv"},{"issue":"3","key":"4790_CR12","doi-asserted-by":"publisher","first-page":"E76","DOI":"10.1002\/ajh.25379","volume":"94","author":"A Mitta","year":"2019","unstructured":"Mitta A, Curtis BR, Reese JA, George JN. Drug-induced thrombocytopenia: 2019 update of clinical and laboratory data. Am J Hematol. 2019;94(3):E76\u20138.","journal-title":"Am J Hematol"},{"issue":"1","key":"4790_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nm973","volume":"10","author":"ST Avecilla","year":"2004","unstructured":"Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, Jin DK, Dias S, Zhang F, Hartman TE, et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med. 2004;10(1):64\u201371.","journal-title":"Nat Med"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04790-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-024-04790-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04790-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T00:02:18Z","timestamp":1727568138000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-024-04790-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,29]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4790"],"URL":"https:\/\/doi.org\/10.1186\/s13256-024-04790-y","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,29]]},"assertion":[{"value":"18 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical committee approval was not required given the article type.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no conflicts to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"451"}}